Download PDF

Work experience

Apr 2006Present

Corporate Officer, Vice President Marketing

IDEV Technologies Inc.

As Corporate Officer and Vice President, Marketing at IDEV, duties included the formulation of the global strategy inclusive of product positioning, commercial branding, messaging, pricing, packaging, forecasting, budgeting and promotion for the commercialization of the SUPERA® Transhepatic Biliary System and the VascuTRAK2 PTA Dilation Catheter. Additional responsibilities included the management of the organization’s intellectual property portfolio worldwide along with leading business development initiatives. Upstream marketing initiatives included driving the strategic direction for R&D product development toward future design innovations of the SUPERA Delivery Catheter along with assisting the management team in all fundraising, merger, acquisition and valuation opportunities for the company.

Jul 2001Feb 2006

Senior Director

As Senior Director, Marketing, responsibilities included the formulation of the marketing strategy, commercial branding and messaging for VNS Therapy in the Epilepsy market along with the management of the Epilepsy departments P&L and staff of (20).In operations, the development of an internal “pull-through” system to qualify patient leads, verify reimbursement coverage, and provide education about the VNS procedure for all field leads. Novel initiatives designed for patients included DTC marketing programs in partnership with WEB MD, retail pharmacies, the Epilepsy Foundation, on-line chat rooms, and direct patient contacts. Field operations consisted of restructuring the sales organization to integrate sales quotas with incentive compensation programs to match organizational objectives. Advocacy initiatives centered on developing thought-leader interest through phase IV clinical trials and advisory boards along with closely working with National foundations such as AES and the National EF to build corporate brand image.

May 1999Jul 2001

Director Marketing

As Director Obesity Marketing, key responsibilities included the formulation of a marketing strategy for MERIDIA® that generated peak product sales of $250M annually. Critical to this strategy was the development of a direct to consumer advertising campaign which generated awareness for the brands value proposition.The business required the creation of the first multi-variant regression model to forecast MERIDIA® demand on the basis of Gross Rating Points (GRPs) relative to DTC promotional spending.In addition, directly supervised all medical promotion, medical education, advocacy development, global integration and communication programs for the brand team. Partnership activities were focused toward NAASO, ASBP and CORE to increase physician education initiatives regarding the treatment of Obesity.Fiscal responsibilities included the management of an $85M promotional budget to sustain the above activities.


Sep 1992May 1996


New York University
Sep 1984May 1988

Bachelors Science




A dynamic visionary with high aptitude for building organizations grounded in sustainable competitive advantages, cutting edge strategies and targeted promotions.Senior marketing and sales expert across multiple health care specialties in the medical device and specialty pharmaceutical industry.

After graduating business school in 1996, Mr. Anzalone applied seven years of direct sales experience into a marketing leadership role in the pharmaceutical industry at BASF.Over the next five years, he launched three pharmaceutical brands and led the restructuring of one mega brand.The last seven years of his career were dedicated to leadership roles and entrepreneurial endeavors in the medical device industry where he restructured one troubled business and commercialized a new start up technology.

His career highlights and success in turning around brands from leadership positions include:

oRestructuring and leading an $85M promotion effort direct to the consumer for a cash payment only pharmaceutical drug in the obesity market that generated peak sales of $250M annually,

oGrowing a fledgling $35M VNS medical device brand to a $120M mega brand in the medical device sector through repositioning, messaging, promotion, and restructuring of the field sales organization,

oPioneering the development of a novel medical device in a large saturated market through multiple design iterations, strategic planning, and commercial launch which generated a $100M value for a new start up business,


Mr. Anzalone has managed a direct reporting staff as large as (20) and a cross functional sales organization of (300). International experience includes Europe and Latin America.


My career objective is to build an organization of excellence based on leadership defined by sound business strategies, insightful business practices and the infinite development of human potential.